Treatment of paroxysmal nocturnal hemoglobinuria.
Patients with PNH may be treated with a number of known agents. As in all patients with a chronic disease, a regimen tolerable over a long period of time must be selected. Knowledge and anticipation of complications and their proper treatment are essential parts in the treatment. When these principals are used, many patients may live reasonable lives for very long periods of time.
D000208:Acute Disease; D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D006457:Hemoglobinuria, Paroxysmal / Q000188:drug therapy* / Q000628:therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy; D065227:Transfusion Reaction
D000728:Androgens; D006493:Heparin; D007501:Iron; D011241:Prednisone